Burel-Vandenbos, F <br/><br/>
MET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma.  [electronic resource] 

 -  Neuropathology and applied neurobiology  Apr 2017 
 - 252-266 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2990 
<br/><br/><label>Standard No.: </label>10.1111/nan.12320  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--analysis<br/>Brain Neoplasms--genetics<br/>Cohort Studies<br/>Female<br/>Gene Amplification<br/>Glioblastoma--genetics<br/>Humans<br/>Immunohistochemistry--methods<br/>Male<br/>Middle Aged<br/>Proto-Oncogene Proteins c-met--analysis